| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allografts Stimulate Cross-Reactive Virus-Specific Memory CD8 T Cells with Private Specificity
|
Brehm, M.A
|
|
|
10 |
8 |
p. 1738-1748
|
artikel
|
| 2 |
Alloimmune Activation Enhances Innate Tissue Inflammation/Injury in a Mouse Model of Liver Ischemia/Reperfusion Injury
|
Shen, X.
|
|
|
10 |
8 |
p. 1729-1737
|
artikel
|
| 3 |
An Innovative Sphincter Preserving Pull-Through Technique with En Bloc Colon and Small Bowel Transplantation
|
Eid, K.R
|
|
|
10 |
8 |
p. 1940-1946
|
artikel
|
| 4 |
A Pitfall in the Current Kidney Allocation Process Using Calculated PRA(CPRA) in Patients Undergoing Desensitization
|
Singh, P.
|
|
|
10 |
8 |
p. 1947
|
artikel
|
| 5 |
Clinical Outcomes for Saudi and Egyptian Patients Receiving Deceased Donor Liver Transplantation in China
|
Allam, N.
|
|
|
10 |
8 |
p. 1834-1841
|
artikel
|
| 6 |
Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit
|
Collett, D.
|
|
|
10 |
8 |
p. 1889-1896
|
artikel
|
| 7 |
De novo Thrombotic Microangiopathy in Renal Allograft Biopsies—Role of Antibody-Mediated Rejection
|
Satoskar, A.A
|
|
|
10 |
8 |
p. 1804-1811
|
artikel
|
| 8 |
Differential Role of Naïve and Memory CD4+ T-Cell Subsets in Primary Alloresponses
|
Golshayan, D.
|
|
|
10 |
8 |
p. 1749-1759
|
artikel
|
| 9 |
Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients
|
Åsberg, A.
|
|
|
10 |
8 |
p. 1881-1888
|
artikel
|
| 10 |
Exogenous Interferon-γ Immunotherapy for Invasive Fungal Infections in Kidney Transplant Patients
|
Armstrong-James, D.
|
|
|
10 |
8 |
p. 1796-1803
|
artikel
|
| 11 |
Expanding the Criteria of Organ Procurement from Donors with Prostate Cancer: The Application of the New Italian Guidelines
|
D’Errico-Grigioni, A.
|
|
|
10 |
8 |
p. 1907-1911
|
artikel
|
| 12 |
Fumagillin for Treatment of Intestinal Microsporidiosis in Renal Transplant Recipients
|
Champion, L.
|
|
|
10 |
8 |
p. 1925-1930
|
artikel
|
| 13 |
Immunosuppressive Agents and CMV Risk in the VICTOR Study
|
Avery, R.K
|
|
|
10 |
8 |
p. 1727-1728
|
artikel
|
| 14 |
Immunotherapy for Invasive Fungal Infections in Transplant Patients: Back to the Future?
|
Hirsch, Hans H.
|
|
|
10 |
8 |
p. 1719-1720
|
artikel
|
| 15 |
Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation
|
Degertekin, B.
|
|
|
10 |
8 |
p. 1823-1833
|
artikel
|
| 16 |
Induction of Indoleamine 2,3-Dioxygenase by Gene Delivery in Allogeneic Islets Prolongs Allograft Survival
|
Dellê, H.
|
|
|
10 |
8 |
p. 1918-1924
|
artikel
|
| 17 |
Infection After Rituximab Therapy in Kidney-Transplant Patients
|
Kamar, N.
|
|
|
10 |
8 |
p. 1950
|
artikel
|
| 18 |
Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab
|
Posselt, A.M
|
|
|
10 |
8 |
p. 1870-1880
|
artikel
|
| 19 |
Is Rituximab Safe to Use in Kidney Transplant Patients?
|
Tydén, G.
|
|
|
10 |
8 |
p. 1949
|
artikel
|
| 20 |
Long-Term Outcomes After Living-Donor Liver Transplantation for Alagille Syndrome: A Single Center 20-Year Experience in Japan
|
Hori, T.
|
|
|
10 |
8 |
p. 1951-1952
|
artikel
|
| 21 |
Long-Term Outcomes of Liver Transplantation in Type 1 Gaucher Disease
|
Ayto, R.M
|
|
|
10 |
8 |
p. 1934-1939
|
artikel
|
| 22 |
Neighborhood Poverty, Racial Composition and Renal Transplant Waitlist
|
Saunders, M.R
|
|
|
10 |
8 |
p. 1912-1917
|
artikel
|
| 23 |
NK Cell Transcripts and NK Cells in Kidney Biopsies from Patients with Donor-Specific Antibodies: Evidence for NK Cell Involvement in Antibody-Mediated Rejection
|
Hidalgo, L.G
|
|
|
10 |
8 |
p. 1812-1822
|
artikel
|
| 24 |
Operative Start Times and Complications After Liver Transplantation
|
Lonze, B.E
|
|
|
10 |
8 |
p. 1842-1849
|
artikel
|
| 25 |
Posttransplant Prophylaxis Strategies for Hepatitis B
|
Gane, E.
|
|
|
10 |
8 |
p. 1721-1722
|
artikel
|
| 26 |
Prophylaxis Against Hepatitis B Recurrence Posttransplantation Using Lamivudine and Individualized Low-Dose Hepatitis B Immunoglobulin
|
Jiang, L.
|
|
|
10 |
8 |
p. 1861-1869
|
artikel
|
| 27 |
Prospective Evaluation of Intraoperative Hemodynamics in Liver Transplantation with Whole, Partial and DCD Grafts
|
Sainz-Barriga, M.
|
|
|
10 |
8 |
p. 1850-1860
|
artikel
|
| 28 |
Rapamycin-Conditioned Donor Dendritic Cells Differentiate CD4+CD25+Foxp3+ T Cells In Vitro with TGF-β1 for Islet Transplantation
|
Pothoven, K.L
|
|
|
10 |
8 |
p. 1774-1784
|
artikel
|
| 29 |
Recombinant Tissue-Type Plasminogen Activator in the Treatment of Acute Renal Artery Thrombosis After Kidney Transplantation
|
Garcia, A.
|
|
|
10 |
8 |
p. 1931-1933
|
artikel
|
| 30 |
Regulatory T Cells Are Critical to Tolerance Induction in Presensitized Mouse Transplant Recipients Through Targeting Memory T Cells
|
Ge, W.
|
|
|
10 |
8 |
p. 1760-1773
|
artikel
|
| 31 |
Reply to ‘A Pitfall in the Current Kidney Allocation Process Using Calculated PRA (CPRA) in Patients Undergoing Desensitization’
|
Cecka, J.M
|
|
|
10 |
8 |
p. 1948
|
artikel
|
| 32 |
Solid Organ Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Multicenter Study of the EBMT
|
Koenecke, C.
|
|
|
10 |
8 |
p. 1897-1906
|
artikel
|
| 33 |
The AJT Report: News and issues that affect organ and tissue transplantation
|
Pondrom, Sue
|
|
|
10 |
8 |
p. 1717-1718
|
artikel
|
| 34 |
The Anti-LFA-1 Trial in Islet Transplantation
|
Oberholzer, J.
|
|
|
10 |
8 |
p. 1725-1726
|
artikel
|
| 35 |
The Jak Inhibitor CP-690,550 Preserves the Function of CD4+CD25brightFoxP3+ Regulatory T Cells and Inhibits Effector T Cells
|
Sewgobind, V.D.K.D
|
|
|
10 |
8 |
p. 1785-1795
|
artikel
|
| 36 |
The Sleeping Giant Awakens—Liver Transplantation in China
|
Fung, J.
|
|
|
10 |
8 |
p. 1723-1724
|
artikel
|
Tijdschrift beschrijving